Terug
Dagbereik
€ 58,01
€ 58,01
52-Weeksbereik
€ 5,67
€ 58,02
Volume
10.846.697
50D / 200D Gem.
€ 49,05
/
€ 26,91
Vorige Slotkoers
€ 58,01
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,4 | 0,4 |
| P/B | 5,1 | 2,9 |
| ROE % | -77,1 | 3,9 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 60,00
+3.4%
Low: € 58,00
High: € 70,00
Forward WPA
-€ 3,17
Omzet Sch.
10 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
-€ 6,47
-€ 6,47 – -€ 6,47
|
18 M | 1 |
| FY2028 |
-€ 4,80
-€ 5,55 – -€ 3,92
|
84 M | 3 |
| FY2027 |
-€ 3,71
-€ 4,55 – -€ 3,15
|
810000 | 3 |
Belangrijkste Punten
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -83,42M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-77,09%
ROIC-52,51%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,02
Current Ratio4,87
Interest Coverage0,00
Waardering
P/E Ratio
-7,39
P/B Ratio5,05
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -129,87M |
| ROE | -77,09% | ROA | -54,04% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -83,42M |
| ROIC | -52,51% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 4,87 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,39 | P/B Ratio | 5,05 |
| P/S Ratio | N/A | PEG Ratio | -0,11 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 959,26M | Enterprise Value | 794,01M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 1,53M | 3,81M | 5,04M |
| Net Income | -129,87M | -116,80M | -83,84M | -69,20M | -52,89M |
| EPS (Diluted) | -25,49 | -24,37 | -20,61 | -20,21 | -17,53 |
| Gross Profit | 0,0 | 0,0 | 1,53M | 3,81M | 5,04M |
| Operating Income | -136,10M | -127,06M | -85,80M | -69,21M | -53,21M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 240,33M | 173,33M | 266,21M | 198,64M | 118,97M |
| Total Liabilities | 50,42M | 26,29M | 21,04M | 12,26M | 14,79M |
| Shareholders' Equity | 189,90M | 147,04M | 245,17M | 186,38M | 104,18M |
| Total Debt | 4,49M | 6,91M | 8,99M | 0,0 | 0,0 |
| Cash & Equivalents | 169,74M | 47,48M | 38,95M | 24,03M | 24,92M |
| Current Assets | 235,24M | 161,78M | 252,69M | 192,97M | 115,60M |
| Current Liabilities | 48,35M | 21,84M | 14,22M | 9,60M | 11,74M |